A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers

Phase 1 Completed 66 enrolled Traws Pharma, Inc.

RandomizedSequentialDouble-blindTreatment

Summary

This is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of TRX-100 (and its major active metabolite TRX-101) in Healthy Volunteers

Timeline

Start: 2024-08-13
Primary completion: 2025-01-16
Completion: 2025-01-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRX-100	Unknown	—	Oral

Indications

No indication recorded.